NOVEL METHODS

COMBINATION THERAPY FOR TREATMENT OF RESTENOSIS

USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND CYCLOPHOSPHAMIDE, VINCRISTINE AND PREDNISONE

CODON OPTIMIZED GLA GENES AND USES THEREOF

METHODS OF TREATING CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS

CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS

COMPOSITION FOR IMPROVING THE SOLUBILITY OF POORLY SOLUBLE SUBSTANCES, COMPLEX FORMULATION AND LIQUID FORMULATION OF AN ACTIVE INGREDIENT

METHODS OF TREATING SUPERFICIAL DIGITAL FLEXOR TENDON INJURIES, DEEP AND SUPERFICIAL MUSCLE/TENDON CONTRACTURE, NAVICULAR SYNDROME, AND SUSPENSORY LIGAMENT INFLAMMATION AND INJURIES IN QUADRUPED ANIMALS

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

GLP-1 COMPOSITIONS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING MOTOR NEURON DISEASES

Oncolytic viruses targeting STAT3

CELL-NANOPARTICLE DRUG DELIVERY SYSTEM AND USE OF THE SAME FOR INHIBITING GROWTH OF TUMOR CELLS AND DIAGNOSING TUMOR CELLS

APPLICATION OF NKG2D CAR-IMMUNOCYTE IN TREATMENT OF ANTI-AGING AND AGE-RELATED DISEASES

Hydroxypropyl beta-cyclodextrin compositions and methods

Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure Disorders

METHOD OF TREATING HYPERTENSION

THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PANCREATIC CANCER USING DEVIMISTAT

ANTI-INFLAMMATORY, ANTI-CANCER, AND ANTI-ANGIOGENIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEREOF

CLEAVABLE CONJUGATES OF CATECHOL COMPOUNDS AND WATER-SOLUBLE POLYMERS AND METHODS OF TREATMENT USING THE SAME

Use of an alkaloid compound in the preparation of products for the prevention and/or treatment of cardiac damage

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

TARGETED DELIVERY OF ANTI-CSF1R ANTIBODIES

INJECTABLE FORMULATIONS OF IBUDILAST

PH20 polypeptide variants, formulations and uses thereof

LFA-1 SIGNALLING MEDIATOR FOR USE IN CANCER THERAPY

Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications

METHOD OF TREATING INFLAMMATORY BOWEL DISEASE WITH A COMBINATION THERAPY OF ANTIBODIES TO IL-23 AND TNF ALPHA

CHIMERIC KLEBICINS

AAV-ABCD1 CONSTRUCTS AND USE FOR TREATMENT OR PREVENTION OF ADRENOLEUKODYSTROPHY (ALD) AND/OR ADRENOMYELONEUROPATHY (AMN)

METHODS OF TREATING COLON CANCER USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY

METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS

METHOD FOR TREATING FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME

METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY

MRNA THERAPY FOR POMPE DISEASE

Treatment of connective tissue injuries

COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES

MEMBRANE-ACTIVE PEPTIDES AND METHODS FOR REVERSIBLE BLOOD- BRAIN BARRIER OPENING

COMPOSITIONS AND METHODS OF TREATMENT COMPRISING TUMOR-TARGETING BACTERIA AND CHEMOTHERAPY OR IMMUNOTHERAPY AGENT

Macrophage Cell Therapy to Treat Orthopedic Injury

Method for Pleurodesis and Delivery of Drugs to the Lung and Pleural Space

Extrahepatic delivery

COMPOUNDS AND COMPOSITIONS FOR TREATING SOLID TUMORS BY INTRATUMORAL ADMINISTRATION

PROTEIN-BOUND CANNABINOID FORMULATIONS AND USES THEREOF

Pemetrexed formulations

PEMETREXED FORMULATIONS

FORMULATIONS OF AZOBENZENE PHOTOREACTIVE COMPOUNDS

DRUG DELIVERY SYSTEMS

Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose

PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF

PH20 polypeptide variants, formulations and uses thereof

Compositions and Methods for Targeting Cancer Stem Cells

CD70 combination therapy

PROTEIN FORMULATIONS AND USES THEREOF

NOVEL IRON COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

REV-ERB AGONISTS

CRYSTALLINE PPAR-DELTA AGONIST

Small Molecule Inhibitors of SARS-CoV-2 Infections

APPARATUS, METHOD, AND USE FOR ULTRASOUND MEDIATED MICROBUBBLE DELIVERY OF PHARMACEUTICAL COMPOSITIONS

GENE THERAPY FOR TREATING HEMOPHILIA A

Glycan-Interacting Compounds and Methods of Use

CATIONIC NANOSTRUCTURES FOR INTRA-CARTILAGE DELIVERY OF CONTRAST AGENTS AND DIAGNOSTIC USES THEREOF

Antibody Compositions and Methods of Use Thereof

METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS BY ADMINISTERING AN ANTI-IL4R-ALPHA ANTIBODY

Rotavirus vaccines

Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s)

POLYMERIC NANOPARTICLE COMPOSITIONS FOR ENCAPSULATION AND SUSTAINED RELEASE OF NEUROMODULATORS

INJECTABLE BIODEGRADABLE POLYMERIC COMPLEX FOR GLUCOSE-RESPONSIVE INSULIN DELIVERY

Treatment of post-bariatric hypoglycemia with exendin (9-39)

GROWTH AND DIFFERENTIATION FACTOR 15 FOR TREATMENT OF PROLIFERATIVE VITREORETINOPATHY THERAPY

Compositions and Methods for Treating Spinal Muscular Atrophy

RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21

COMPOSITIONS AND METHODS FOR TREATING HEMATOPOIETIC MALIGNANCY

BCMA-TARGETED CHIMERIC ANTIGEN RECEPTORS

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE WITH CYCLODEXTRINS

A METHOD OF TREATING FOOT ROT

BIODEGRADABLE POLYMER DELIVERY SYSTEM FOR EXTENDED DELIVERY OF TESTOSTERONE

COMPOSITIONS COMPRISING FLUMAZENIL AND NALTREXONE AND METHODS FOR USE THEREOF

AMORPHOUS SOLID DISPERSIONS

ANTIBIOTIC COMBINATION THERAPIES

MICROSUSPENSION AGAINST PARASITES AND METHOD FOR OBTAINING SAME

Method of preventing and treating chemotherapy-induced alopecia

CARBOHYDRATE CROSSLINKER

Therapeutic use of mitochondria and combined mitochondrial agents

DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES IN ELDERLY PATIENTS

ANTI-NRP1A ANTIBODIES AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES

BIPHASIC SUBCUTANEOUS DOSING REGIMENS FOR ANTI-VLA-4 ANTIBODIES

COMBINATION THERAPY OF ANTI-PD-1 ACTIVE AGENT, ANTI-TIM-3 ACTIVE AGENT, AND ANTI-LAG-3 ACTIVE AGENT FOR TREATING CANCER

miRNA PROFILING COMPOSITIONS AND METHODS OF USE

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

Hydrogel cross-linked hyaluronic acid prodrug compositions and methods

STABILIZED ANTIBODY PROTEIN SOLUTIONS

Zika vaccines and immunogenic compositions, and methods of using the same

Treatment of stress disorders using acetylcholine release inhibiting neurotoxic proteins to reduce stress levels

Hard Tissue Therapeutics

COLLAGEN 7 COMPOSITIONS AND METHODS OF USING THE SAME

COMPOSITION BASED ON AUTOLOGOUS PLATELET CONCENTRATES AND A COLOSTRUM ISOLATE MIXTURE OF BIOLOGICAL FACTORS FOR USE IN THE TREATMENT OF CONDITIONS REQUIRING TISSUE REPAIR AND REGENERATION

SYSTEMS AND METHODS FOR REPAIRING SPINAL DISC INJURY OR TREATING SPINAL DISC DISEASE

ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

Methods for the use of 5′-adenosine diphosphate ribose (ADPR)

METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS

METHODS OF TREATING NEUROLOGICAL VENTILATORY INSUFFICIENCY

PEMETREXED FORMULATIONS

Methods of treatment

MORPHINE FORMULATIONS

ADMINISTRATION OF ANTIBIOTIC COMPOUNDS FOR THE TREATMENT OF STREPTOCOCCAL INFECTIONS FOR THE TREATMENT OF PSORIASIS

PHARMACEUTICAL COMBINATION FOR MOOD DISORDERS

PHARMACEUTICAL COMPOSITION COMPRISING UBIQUINONE-5 AND METHOD OF USE THEREOF

LIPOSOMES ENCAPSULATING ADENOSINE

PEPTIDE FORMULATIONS AND METHODS OF USE

CARIPRAZINE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD AND APPLICATION THEREOF

Formulations for parenteral delivery of compounds and uses thereof

Methods of intravenous administration of glyburide

TREATMENT OF DISC DEGENERATIVE DISEASE AND STIMULATION OF PROTEOGLYCAN SYNTHESIS BY FIBROBLAST CONDITIONED MEDIA AND FORMULATIONS THEREOF

GENERATION OF THERAPEUTIC CELLS USING EXTRACELLULAR COMPONENTS OF TARGET ORGANS

METHODS FOR DETERMINING AND ACHIEVING THERAPEUTICALLY EFFECTIVE DOSES OF ANTI-CD47 AGENTS IN TREATMENT OF CANCER

METHODS FOR TREATING AND DIAGNOSING BLINDING EYE DISEASES

BUNYAVIRALES VACCINE

TYPE E BOTULINUM TOXIN TO TREAT BOTULISM

METHODS OF REDUCING COLLAGENASE-MEDIATED BRUISING IN A SUBJECT HAVING CELLULITE

TREATMENT OR PREVENTION OF A DISEASE OR DISORDER

PREVENTION AND/OR TREATMENT OF HEARING LOSS OR IMPAIRMENT

TREATMENT METHODS USING BOTULINUM TOXINS

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF HEADACHES

Bortezomib compositions

GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS

FLUMAZENIL FORMULATIONS FOR SUBCUTANEOUS INJECTION AND METHODS OF TREATMENT USING GABA RECEPTOR MODULATORS

TREATMENT OR PREVENTION OF HIV INFECTION

MICROSPHERE FORMULATIONS COMPRISING BTK INHIBITORS AND METHODS FOR MAKING AND USING THE SAME

Fulvestrant formulations and methods of their use

T-cell modulatory multimeric polypeptides and methods of use thereof

Amino acid derivative of glucosamine stimulating extracellular matrix synthesis and pharmaceutical composition comprising the same

Using Targeted Radiotherapy (TRT) to Drive Anti-Tumor Immune Response to Immunotherapies

PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HUMAN TSLP RECEPTOR ANTIBODY

METHOD OF INDUCING AN IMMUNE RESPONSE

USE OF B-CELL LYMPHOMA 2 (BCL-2) INHIBITOR AND PHARMACEUTICAL COMPOSITION FOR TREATING CELLULAR SENESCENCE-RELATED SKIN DISEASES

CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS

Method of treating cancer using selective estrogen receptor modulators

MRNA delivery composition

Nucleic Acid-Based Therapy of Muscular Dystrophies

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS

CONCENTRATE CONTAINING POORLY SOLUBLE DRUG AND EMULSION PREPARED THEREFROM

STABLE, INJECTABLE NORADRENALINE SOLUTIONS FREE OF ANTIOXIDANTS

ETOPOSIDE TONIRIBATE FORMULATION

METHODS AND COMPOSITIONS FOR SUSTAINED RELEASE MICROPARTICLES FOR OCULAR DRUG DELIVERY

TOPICAL COMPOSITIONS AND METHODS FOR TREATING PAIN

INHIBITION OF PLATELET AGGREGATION USING ANTI-HUMAN GPVI ANTIBODIES

PROCESS FOR PREPARATION OF PURE NALTREXONE DECANOATE, ITS SALTS, COMPOSITION AND METHOD OF USE THEREOF

Truncated Evans Blue modified fibroblast activation protein inhibitor, preparation method and application thereof

Injectable preparation

Bismuth-Gadolinium Nanoparticles

Methods of Treating Cervical Dystonia in a Subject Having Underlying Condition(s)

ISCHEMIA/REPERFUSION INJURY

TREATMENT OF RADICULAR PAIN WITH CELL-FREE AMNIOTIC FLUID

METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF GRAFT VERSUS HOST DISEASE

COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Antiviral Prodrugs and Pharmaceutical Compositions Thereof

NEUROBLASTOMA TREATMENT WITH TAUROLIDINE HYDROLYSIS PRODUCTS

PEMETREXED FORMULATIONS

METHOD OF TREATING SCLC AND MANAGING THROMBOCYTOPENIA

Lurbinectedin Composition and Methods Making the Same

4-PHENYL-TETRAHYDROPYRIDINE DERIVATIVES FOR TREATING HEARING DISEASES

BIPHENYL PYRROLIDINE AND BIPHENYL DIHYDROIMIDAZOLE DERIVATIVES FOR INHIBITING ACTIVITY OF 5-HT7 SEROTONIN RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT

PHARMACEUTICAL COMPOSITION

Prevention of kidney injury induced by hemolytic reaction

ADMINISTRATION OF ANTIPURINERGIC COMPOSITIONS FOR TREATING NERVOUS SYSTEM DISORDERS

METHODS FOR PRODUCTION OF MSC-DERIVED EXOSOMES

STABLE COMPOSITIONS FOR INCRETIN MIMETIC COMPOUNDS

NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS

GENE THERAPY FOR CEROID LIPOFUSCINOSES

IMMUNOGENIC PEPTIDE AGAINST GROUP A STREPTOCOCCUS

MEANS AND METHODS FOR TREATING AND DIAGNOSING FIBROSIS OR FIBROSIS-ASSOCIATED DISEASES

Radiopharmaceuticals, radioimaging agents, and uses thereof

N-AROMATIC AMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF

SYSTEM FOR TREATING A PATIENT

MEDICAL DEVICE CONTAINING A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT, AND A CAKE COMPOSITION COMPRISING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT.

VISCOSITY-REDUCING EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS

RESPIRATORY VIRUS NUCLEIC ACID VACCINES

FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE

Controlled-release PTH compound

USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK

Stable liquid compositions of glucagon

PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER

METHODS OF TREATING EYE DISORDERS

METHODS AND COMPOSITIONS FOR TREATING SKELETAL MUSCULAR DYSTROPHY

COMPOSITION FOR BONE REGENERATION CONTAINING HYDROGEL AND STEM CELL SPHEROID, AND USE THEREOF

CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL ADJUVANT THERAPIES

METHODS FOR THE TREATMENT OF BETA-THALASSEMIA

TREATMENT OF POST-OPERATIVE JOINT PAIN WITH POLYSULFATED POLYSACCHARIDES

NOVEL COMBINATION TREATMENT FOR ACUTE MYELOID LEUKEMIA (AML)

THERAPEUTIC TREATMENT OF BREAST CANCER BASED ON C-MAF STATUS

NON-SURGICAL PREVENTION OF UNPLEASANT ODOR IN MEATS AND AGGRESSIVE OR SEXUAL BEHAVIOR IN MALE RUMINANTS

PREVENTION OF ESTRUS IN SOW AND RUMINANTS

COMPOSITIONS FOR NON-SURGICAL PREVENTION OF BOAR TAINT AND AGGRESSIVE BEHAVIOR

METHODS FOR CONTROLLING AND PREDICTING RECOVERY AFTER NMBA ADMINISTRATION

USE OF FOLIC ACID AND FOLATE MODIFICATION IN INDUCING B-CELL IMMUNE TOLERANCE AND TARGETING mIgM-POSITIVELY-EXPRESSED B-CELL LYMPHOMA

Therapeutic agent composition and method of use, for treatment of mild congnitive impairment, depression, and psychological disorders

Ifetroban Treatment for Systemic Sclerosis

Compositions and Methods for Treating Defects in Avascular Cartilaginous Tissue by Directly Administering One or More Metabolites of Simvastatin

METHOD OF TREATING POST-TRAUMATIC STRESS DISORDER

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES

ANTIBODY THAT BINDS TO VEGF-A AND ANG2 AND METHODS OF USE

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

Methods for modulating an immune response

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

ANTI-IL-36R ANTIBODY FORMULATIONS

STABLE LIQUID GONADOTROPIN FORMULATION

Formulations of vancomycin

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

PREPARATION OF TEREVALEFIM AND FORMULATIONS THEREOF

ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER

METHODS OF INTRAVENOUSLY ADMINISTERING SOTALOL

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

Anti-PfRH5 antibodies and antigen-binding fragments thereof

ANTIBODY-COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS

PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES

METHODS FOR TREATING DIGITALLY-IDENTIFIED IL-4/IL-13 RELATED DISORDERS

Coronavirus vaccine

METHOD FOR LYOPHILIZING LIVE VACCINE STRAINS OF FRANCISELLA TULARENSIS

NUCLEOTIDE SEQUENCE EXPRESSING AN EXOSOME-ANCHORING PROTEIN FOR USE AS VACCINE

EFFECTIVE DOSAGE OF RECOMBINANT SERPIN-FC FUSION PROTEIN FOR USE IN A METHOD OF TREATING AAT DEFICIENCY IN A SUBJECT

Method to Improve Neurologic Outcomes in Temperature Managed Patients

VEGFR fusion protein pharmaceutical composition

KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA

TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION

CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS

GANAXOLONE FOR USE IN TREATMENT OF SUPER REFRACTORY STATUS EPILEPTICUS

REACTIVATION OF mTOR IN ACUTE KIDNEY INJURY (AKI)

PARENTERAL TREATMENTS INVOLVING AMINOADAMANTANE DERIVATIVES

Stabilized formulations of lipid nanoparticles

BENDAMUSTINE SOLID DISPERSIONS AND CONTINUOUS INFUSION

SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND METHODS OF MAKING THEREOF

-acetylcysteine compositions and methods

ADMINISTRATION OF A PSYCHEDELIC COMPOUND

Color and symbol coded display on a digital badge for communicating permission to approach and activate further digital content interaction

PH20 polypeptide variants, formulations and uses thereof

IMMUNOSTIMULATORY AGONISTIC ANTIBODIES FOR USE IN TREATING CANCER

PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION

THERAPIES AND METHODS TO TREAT TLR2-MEDIATED DISEASES AND DISORDERS

GLP-1 AND GLUCAGON DUAL AGONIST PEPTIDES WITH IMPROVED BIOLOGICAL STABILITY

MANUFACTURE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE (III)] AND COMPOSITIONS THEREOF

IMMUNOTHERAPY OF SKIN CANCER USING MPLA-LOADED HPG NANOPARTICLES

Pharmaceutical Formulations

Non-protein Clostridial toxin compositions

Non-protein clostridial toxin compositions

METHOD OF DELIVERING GONADOTROPIN RELEASING HORMONE OR AN ANALOGUE THEREOF INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE

Lyophilized formulation

Bi-functional co-polymer use for ophthalmic and other topical and local applications

MEDICAL USE OF TAFOXIPARIN

PCSK9 INHIBITORS AND METHODS OF TREATMENT USING SAME

RNAI AGENTS FOR HEPATITIS B VIRUS INFECTION

NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF

SOLID PHARMACEUTICAL COMPOSITIONS COMPRISING BIOPTERIN DERIVATIVES AND USES OF SUCH COMPOSITIONS

TOPOTECAN FOR PROLIFERATIVE VITREORETINOPATHY

COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIPID-RELATED DISORDERS

Pharmaceutical Composition Containing Elemene, Preparation Method Therefor, And Use Thereof

STROKE TREATMENT

COMPOSITIONS AND METHODS FOR RELIEVING PAIN

TREATING NEUROPATHIC PAIN IN SPINAL CORD INJURED INDIVIDUALS

FUSOGENIC LIPID NANOPARTICLES FOR TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN FUSOGENIC LIPID NANOPARTICLES AND METHODS OF MANUFACTURE AND USE THEREOF FOR THE TARGET CELL-SPECIFIC PRODUCTION OF A THERAPEUTIC PROTEIN AND FOR THE TREATMENT OF A DISEASE

Systems and methods for producing injectable enhanced stem cell exosomes, improved exosomes and methods of use

SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE

Oxysterols and methods of use thereof

Compositions and methods for inhibiting the activity of LAR family phosphatases

Nanostructured Gels Capable of Controlled Release of Encapsulated Agents

ALTERNATIVE SURFACTANTS AS STABILIZERS FOR THERAPEUTIC PROTEIN FORMULATIONS

Stabilized Formulations Containing Anti-IL-33 Antibodies

SEXUALLY TRANSMITTED DISEASE VACCINES

Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)

TREATMENT OF CORONAVIRUS INFECTIONS

UNIT DOSE PHARMACEUTICAL OF A DRY POWDER OF ONE OR MORE GLUCOCORTICOID OR MINERALOCORTICOID FLUDROCORTISONE ACETATE AND/OR TRIAMCINOLONE ACETONIDE COMPRISED IN A SYRINGE

Dosing regimen for sedation with CNS 7056 (Remimazolam)

VETERINARY COMPOSITION FOR DAIRY RUMINANTS FOR TREATMENT OF MILK FEVER

CANCER TREATMENT WITH TLR AGONIST

Methods and Compositions for Treating Pruritus, Xerosis, and Associated Disease Using CCR3-Inhibitors

MULTIPLE MYELOMA TREATMENT

Treatment of Upper Facial Lines

SIRNA THERAPY FOR TRANSTHYRETIN (TTR) RELATED OCULAR AMYLOIDOSIS

ANTIGEN-PRESENTING CELL-MIMETIC SCAFFOLDS AND METHODS FOR MAKING AND USING THE SAME

Methods of Treating High Risk Multiple Myeloma

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

Dosages

SHANK3 GENE THERAPY APPROACHES

METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE USING CONSERVED ELEMENT CONSTRUCTS

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES

METHODS AND MATERIALS FOR TISSUE ABLATION

Liquid pharmaceutical composition

METHOD FOR SCREENING INDIVIDUAL TUMOR NEOANTIGEN PEPTIDE, AND VACCINE FORMULATION THEREOF

METHOD TO CREATE PERSONALIZED CANINE CANCER VACCINES

PHARMACEUTICAL COMPOSITION IN THE FORM OF A HYDROGEL COMPRISING ORANGE-DERIVED EXTRACELLULAR VESICLES

AAV-Mediated Gene Transfer for Retinopathy

METHOD FOR TREATING ISCHEMIA CONDITION OF TISSUE

ALLOGENIC UMBILICAL CORD STEM CELLS FOR TREATING SEVERE RESPIRATORY CONDITIONS

METHODS EMPLOYING GASEOUS NITRIC OXIDE FOR INHIBITING TUMOR GROWTH

Methods for therapeutic administration of messenger ribonucleic acid drugs

Ophthalmic gel compositions of bimatoprost and timolol and associated methods